NVO Articles, Novo Nordisk A/S - From 03/29/24

The first quarter of 2024 has turned out to be a blockbuster for most asset classes, and the strong performances have left investors worried abou...

The first quarter of 2024 has turned out to be a blockbuster for most asset classes, and the strong performances have left investors worried abou...

Raymond James has initiated coverage on Scholar Rock Holding (NASDAQ:SRRK), supported by the potential value with a couple of key pr...

A recent study suggests that despite Novo Nordisk A/S’s (NYSE:NVO) high monthly charge of close to $1,000 for its blockbuster diabe...

Some major U.S. health insurers, including CVS Health Inc (NYSE:CVS), Elevance Health Inc (NYSE:ELV), and Kaiser Permanente wil...

Some major U.S. health insurers, including CVS Health Inc (NYSE:CVS), Elevance Health Inc (NYSE:ELV) and Kaiser Permanente, will start reimburs...

Monday, Biohaven’s (NYSE:BHVN) CEO, Vlad Coric, joined CNBC Fast Money to discuss the weight loss drug wars and the company...

Raymond James Financial, Inc. (NYSE: RJF) is now valued more highly than JPMorgan Chase & Co. (NYSE: JPM), according to Jim Cramer. &quo...

Novo Nordisk A/S (NYSE:NVO), the maker of popular diabetes and weight loss drugs like Ozempic and Wegovy, is delving into artificial intellige...

Scores of patients are reportedly taking legal action against pharmaceutical giants Eli Lilly And Co (NYSE:LLY) and Novo Nordisk A/S...